• Legend
  • corporate
  • finance
  • sciences
  • Servier and Pfizer announce FDA clearance of IND application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia

    read more
  • Five Additional Leading Physicians to Join Cellectis Clinical Advisory Board

    read more download
  • Cellectis Reports 4th Quarter and Full Year 2016 Financial Results

    read more download
  • Cellectis to Present at the LEERINK Partners 6th Annual Global Healthcare Conference on Thursday, February 16, 2017 at 1:30pm ET in New York

    read more download
  • FDA Grants Cellectis IND Approval to Proceed with the Clinical Development of UCART123, the First Gene Edited Off-the-Shelf CAR T-Cell Product Candidate developed in the U.S.

    read more download